Bob Hopkins Recent News
How Much Litigation Risk Is Priced Into Johnson & Johnson?
Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom
After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk
BofA Lowers Boston Scientific Revenue Estimates On FDA Warning, But Keeps Buy Rating
BofA: Medtronic's Growth 'Should Continue To Surprise'
Nevro Initiated With Buy Rating At Bank Of America
Bank Of America Upgrades HeartWare; Downgrades EndoChoice, Tandem
BofA's Favorite MedTech Picks Right Now
BofA Upgrades Baxter International On 'Margin Story,' But Valuation Is Rich
UPDATE: Bank Of America Raises PT On Intuitive Surgical On Bullish Growth Outlook
Bank Of America Raises Intuitive Surgical Price Target
UPDATE: Bank of America Raises PT on Edwards Lifesciences Corp. Following Analyst Day
UPDATE: Bank Of America Reiterates On Medtronic Post COV Financing
UPDATE: Bank Of America Reiterates On Medtronic
Bank Of America Impressed By Intuitive Surgical Following Congress
UPDATE: Bank Of America Reiterates On Johnson & Johnson On Likely EPS Headwinds
UPDATE: Bank Of America Moves CareFusion Corporation To No Rating, Removes PT On BDX Agreement
Bank Of America Tweaks Numbers For St. Jude Medical, Inc. Lower On F/X, Portico
UPDATE: Bank Of America Reiterates On Baxter International Inc. On Mixed Factors
UPDATE: Bank Of America Reinstates Coverage Of Medtronic, Inc.
Bank Of America Remains Optimistic On Johnson & Johnson
UPDATE: Bank Of America Downgrades C.R. Bard
UPDATE: Bank Of America Reiterates On Abbott Laboratories Following Detailed Analysis